| Literature DB >> 34121511 |
Kishoree Sangarapillai1, Benjamin M Norman1, Quincy J Almeida1.
Abstract
Background. Exercise is increasingly becoming recognized as an important adjunct to medications in the clinical management of Parkinson's disease (PD). Boxing and sensory exercise have shown immediate benefits, but whether they continue beyond program completion is unknown. This study aimed to investigate the effects of boxing and sensory training on motor symptoms of PD, and whether these benefits remain upon completion of the intervention. Methods. In this 20-week double-blinded randomized controlled trial, 40 participants with idiopathic PD were randomized into 2 treatment groups, (n = 20) boxing or (n = 20) sensory exercise. Participants completed 10 weeks of intervention. Motor symptoms were assessed at (week 0, 10, and 20) using the Unified Parkinson's Disease Rating Scale (UPDRS-III). Data were analyzed using SPSS, and repeated-measures ANOVA was conducted. Results. A significant interaction effect between groups and time were observed F(1, 39) = 4.566, P = .036, where the sensory group improved in comparison to the boxing group. Post hoc analysis revealed that in comparison to boxing, the effects of exercise did not wear off at washout (week 20) P < .006. Conclusion. Future rehabilitation research should incorporate similar measures to explore whether effects of exercise wear off post intervention.Entities:
Keywords: Parkinson’s disease; Parkinson’s disease SAFEx; boxing; exercise; high-intensity; rehabilitation; sensory
Mesh:
Year: 2021 PMID: 34121511 PMCID: PMC8414806 DOI: 10.1177/15459683211023197
Source DB: PubMed Journal: Neurorehabil Neural Repair ISSN: 1545-9683 Impact factor: 3.919
Figure 1.CONSORT flow diagram illustrating participant recruitment, randomization and flow over the course of the study.
Demographic Characteristics (Standard Deviation in Parentheses).
| RSB | PD SAFEx™ | |
|---|---|---|
| Number of participants (n) | 20 | 20 |
| Age (years) | 64.2 (9.8) | 65.1 (9.2) |
| Number of years since diagnosis | 6.38 (4.9) | 7.82 (5.2) |
| Program adherence (%) | 96% (2.26) | 98% (1.65) |
| Baseline disease severity | 28.38 (11.41) | 28.44 (14.23) |
| Hoehn and Yahr stage | 2.5 | 2.5 |
| Levodopa equivalent dose (mg/d) | ||
| Pre | 612.13 (220.75) | 608.11 (238.44) |
| Post | 613.13 (232.12) | 608.23 (258.25) |
| Washout | 602.13 (225.60) | 599.01 (242.42) |
Abbreviations: RSB, Rock Steady Boxing, Inc; PD SAFExTM, Parkinson’s disease sensory attention focused exercise.
Any significant findings will be marked with an asterisk (*).
Primary Outcome Measure (UPDRS-III Scores) as Group Averages (Standard Deviation in Parentheses).
| Within-group differences (pre-post): mean ± SE (95% CI) (pre-washout): mean ± SE (95% CI) | Between-group differences mean ± SE (95% CI) | ||||||
|---|---|---|---|---|---|---|---|
| Groups | MDC* (greater than 5 points)[ | MDC* (greater than 5 points)[ | |||||
| PD SAFExTM | RSB | PD SAFExTM | RSB | PD SAFExTM vs RSB | |||
| UPDRS-III | |||||||
| Pre | 28.8 (10.19) | 28.37 (11.22) | .5 ± 3.3 (−6.3 to 7.3) | ||||
| Post | 19.60 (10.03) | 33.41 (9.67) | 9.2 ± 1.1 (.4 to 6.1) | −5.04 ± .8 (−.9 to −3.4) | 13.8 ± 3.1 (−20.1 to −7.4) | ||
| Washout | 20.45 (10.95) | 34.14 (10.69) | 8.35 ± 1.2 (.2 to 4.2) | −5.77 ± .9 (−.76 to −3.49) | 13.7 ± 3.3 (−20.4 to −6.98) | ||
Abbreviations: RSB, Rock Steady Boxing, Inc; PD SAFExTM, Parkinson’s disease sensory attention focused exercise; UPDRS-III, Unified Parkinson’s Rating Scale subsection III; MDC, minimal detectable change.
Figure 2.Change in disease severity (UPDRS-III) at pre-assesment, post-assessment, and washout for the boxing and sensory exercise groups. UPDRS-III, Unified Parkinson’s Rating Scale subsection III.
Secondary Outcome Measures and Significant Main Effects. (Standard Deviation in Parentheses).
| RSB | PD SAFEx™ | Effect | |
|---|---|---|---|
| Stride length (m) | |||
| Pre | 1.48 (.24) | 1.46 (.13) | Main effect of group: |
| Post | 1.47 (.22) | 1.73 (.52) | Interaction effect of group ∗ time:
|
| Washout | 1.39 (.22) | 1.76 (.38) | |
| Stride velocity (m/s) | |||
| Pre | 1.40 (.17) | 1.433 (.13) | Main effect of group: |
| Post | 1.36 (.18) | 1.53 (.20) | Interaction effect of group ∗ time:
|
| Washout | 1.32 (1.18) | 1.55 (.21) | |
| CHAMPS | |||
| Pre | 3149.82 (2040.11) | 3844.71 (2963.80) | No significant effects or interactions |
| Post | 3146.17 (2059.17) | 3847.99 (2483.90) | |
| Washout | 3147.20 (2102.12) | 3850.9 (2863.80) | |
| PDQ-39 | |||
| Pre | 31.4 (21.97) | 35.33 (23.52) | Significant effect of time: |
| Post | 26.20 (30.62) | 30.62 (21.75) | |
| Washout | 26.35 (21.53) | 30.71 (21.29) | |
Abbreviations: RSB, Rock Steady Boxing, Inc, PD SAFExTM, Parkinson’s disease sensory attention focused exercise; UPDRS-III, Unified Parkinson’s Rating Scale subsection III; PDQ-39, Parkinson’s Disease Questionnaire-39; CHAMPS, Community Health Activities Model Program for Seniors. Note: Significance is indicated by an ∗.